The way FDA analyzes recalls and applies its list of root-cause possibilities needs a dose of transparency.
News & Features
Becton Dickinson is suing competitor Cytek, claiming that the company stole information after hiring several former BD employees.
Edwards picks up a CE mark for the Centera valve in a move that could strengthen its position in the growing TAVR market.
The company has teamed up with the International Olympic Committee to bring precision medicine to the winter games.
Here's a look at the companies that broke into the ranks of the top 100 medical device and diagnostics companies last year.
Designed for extended wear, the adhesive firmly bonds to the wearer’s skin while remaining comfortable, 3M reports.
LivaNova said it will pay up to $250 million for TandemLife, a deal that will significantly bolster its cardiac surgery portfolio.
Pricing headwinds under the Medtronic agreement is expected to slow Mazor's growth in 2018, but longer-term prospects are promising.
FDA's recent approval of stroke detection software paves the way for Artificial Intelligence applications to thrive on the healthcare landscape.
The wearables company said it will acquire Twine Health, a health coaching platform aimed at lowering healthcare costs.
Investors ranging from Google's parent company to pharma giants Novartis and AstraZeneca have shown interest in Rani Therapeutics, which is developing an ingestible drug-delivery pill.
Reports that the online retailer wants to become a major hospital supplier is giving some in medtech reason to worry.
Studies on the room disinfection technology using short-wavelength ultraviolet radiation demonstrate benefits and explore strategies for use.
A $45 million funding round completed by DiaCarta to help develop a liquid biopsy test for colorectal cancer is just the latest proof that venture capitalists continue to see liquid biopsy companies as an attractive investment.